Smoking and susceptibility to thyroid cancer: An inverse association with CYP1A1 allelic variants

Endocrine-Related Cancer

Volumn 13, Issue 4, 2006, Pages 1185-1193

  Bufalo, Natassia E ^a   Leite, Janaina L ^a   Guilhen, Ana C T ^a   Morari, Elaine C ^a   Granja, Fabiana ^a   Assumpcao, Ligia V M ^a   Ward, Laura S ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; PROTEIN GSTO1; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANAMNESIS; ARTICLE; ASPIRATION BIOPSY; BLOOD SAMPLING; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CIGARETTE SMOKING; CODON; CONTROLLED STUDY; DNA EXTRACTION; ETHNICITY; FEMALE; FOLLICULAR CARCINOMA; GENETIC VARIABILITY; GENOTYPE; GOITER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PAPILLARY CARCINOMA; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THYROID ADENOMA; THYROID CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; VARIATION (GENETICS);

EID: 33846783311     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-06-0002     Document Type: Article

References (27)

1. Agundez JA 2004 Cytochrome P450 gene polymorphism and cancer. Current Drug Metabolism 5 211-224.
2. Autrup H 2000 Genetic polymorphisms in human xenobiotic metabolizing enzymes as susceptibility factors in toxic response. Mutation Research 464 65-76.
3. Burgess JR 2002 Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid 12 141-149.
4. Castro MR & Gharib H 2005 Continuing controversies in the management of thyroid nodules. Annals of Internal Medicine 142 926-931.
5. Coeli CM, Brito AS, Barbosa FS, Ribeiro MG, Sieiro AP & Vaisman M 2005 Incidence and mortality from thyroid cancer in Brazil. Arquivos Brasileiros de Endocrinologia e Métabolismo 49 503-509.
6. Doll R & Peto R 1981 The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. Journal of the National Cancer Institute 66 1191-1308.
7. Granja F, Morari J, Morari EC, Correia LA, Assumpcao LVM & Ward LS 2004a GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Letters 209 129-137.
8. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LVM & Ward LS 2004b Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Letters 210 151-157.
9. Granja F, Morari EC, Assumpcao LVM & Ward LS 2005 GSTO polymorphism analyses in thyroid nodules suggest that GSTO1 variants do not influence the risk for malignancy. European Journal of Cancer Prevention 14 277-280.
10. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W & Mack WJ 2000 Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control 11 163-170.
11. International Agency for Research on Cancer 2002 Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risk. vol 83. Washington DC: IARC Press.
12. Iribarren C, Haselkorn T, Tekawa IS & Friedman GD 2001 Cohort study of thyroid cancer in a San Francisco Bay area population. International Journal of Cancer 93 745-750.
13. Jacob P, Bogdanova TI, Buglova E, Chepurniy M, Demidchik Y, Gavrilin Y, Kenigsberg J, Meckbach R, Schotola C, Shinkarev S et al. 2006 Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accident. Radiation Research 165 1-8.
14. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N & Watanabe J 1990 Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Letters 263 131-133.
15. Kawajiri K, Nakachi K, Imai K, Watanabe J & Hayashi S 1993 The CYP1A1 gene and cancer susceptibility. Critical Reviews in Oncology and Hematology 14 77-87.
16. Levitz JS, Bradley TP & Golden AL 2004 Overview of smoking and all cancers. Medical Clinics of North America 88 1655-1675.
17. Liu S, Semenciw R, Ugnat AM & Mao Y 2001 Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. British Journal of Cancer 85 1335-1339.
18. Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, Hallquist A, Jin F, Kolonel L, La Vecchia C et al. 2003 A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control 14 773-785.
19. Morari EC, Leite JLP, Granja F, Assumpcao LVM & Ward LS 2002 The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiology Biomarkers & Prevention 11 1485-1488.
20. Navarro Silvera SA, Miller AB & Rohan TE 2005 Risk factors for thyroid cancer: a prospective cohort study. International Journal of Cancer 116 433-438.
21. Parkin D, Whwlan S, Ferlay J, Raymond L & Young J 1997 Cancer Incidence in Five Continents. vol VII. IARC Science Publishing.
22. Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC & Strachan MW 2005 Changing trends in incidence and mortality of thyroid cancer in Scotland. Clinical Endocrinology 62 156-162.
23. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA & Boice JD, Jr 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiation Research 141 259-277.
24. Trell L, Korsgaard R, Janzon L & Trell E 1985 Distribution and reproducibility of aryl hydrocarbon hydroxylase inducibility in a prospective population study of middle-aged male smokers and nonsmokers. Cancer 56 1988-1994.
25. Vineis P 2002 The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181-182 457-462.
26. Wogan GN, Hecht SS, Felton JS, Conney AH & Loeb LA 2004 Environmental and chemical carcinogenesis. Seminars in Cancer Biology 14 473-486.
27. Wu MT, Lee JM, Wu DC, Ho CK, Wang YT, Lee YC, Hsu HK & Kao EL 2002 Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan. British Journal of Cancer 87 529-532.